Latest Aarti Pharma Labs stock price

Aarti Pharma Labs P/E Ratio

AARTIPHARM • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
27.88
High Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 27.88
Current Price ₹747.25
EPS (TTM) ₹30.06
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 15.9
Historical Range 13.43 - 18.37
Percentile 100.0%

Sector Context

Sector Average 49.29
Sector Median 34.47
Sector Rank #11 of 66
Sector Percentile 16.7%

Earnings Breakdown (TTM)

TTM EPS ₹24.32
Sept 2025 ₹3.08
Mar 2025 ₹9.75

Key P/E Ratio Insights for Aarti Pharma Labs

  • Stock appears overvalued with PE of 27.88, suggesting caution for new investments
  • Current PE is 75.3% above historical average
  • Trading at discount to sector average PE of 49.29

View the AARTIPHARM equity price for detailed stock performance.

P/E Ratio Historical Trend for Aarti Pharma Labs

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 18.37 27.51 ₹505.35 NSE Moderate
2023 13.43 21.47 ₹288.25 NSE Low

Sector P/E Ratio Comparison

Comparing Aarti Pharma Labs with other companies in Healthcare sector
Sector Average
49.29
Sector Median
34.47
Lowest P/E
9.01
Highest P/E
285.5
Companies
66
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low
Lincoln Pharmaceuticals LINCOLN 12.02 ₹974 Low
QMS Medical Allied Servi… QMSMEDI 12.82 ₹177 Low
Venus Remedies VENUSREM 14.27 ₹995 Low
Bliss GVS Pharma BLISSGVS 16.62 ₹1,973 Moderate
RPG Life Sciences RPGLIFE 17.94 ₹3,861 Moderate
Gennex Laboratories GENNEX 17.99 ₹329 Moderate
Dr Reddys Laboratories DRREDDY 18.27 ₹104,830 Moderate